Achieve Stock Analysis

ACHV
 Stock
  

USD 3.64  0.30  8.98%   

The big decline in price over the last few months for Achieve Life Sciences could raise concerns from sophisticated investors as the firm is trading at a share price of 3.64 on 19,172 in volume. The company directors and management failed to add value to investors and position the firm supply of money to exploit market volatility in August. However, diversifying your holdings with Achieve Life Sciences or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.37. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Achieve Life partners.
Please continue to Trending Equities.
  
The Achieve Life stock analysis report makes it easy to digest most publicly released information about Achieve Life and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Achieve Stock analysis module also helps to analyze the Achieve Life price relationship with some important fundamental indicators such as market cap and management efficiency.

Achieve Stock Analysis Notes

About 30.0% of the company shares are held by institutions such as insurance companies. The book value of Achieve Life was presently reported as 1.36. The company recorded a loss per share of 3.66. Achieve Life Sciences had not issued any dividends in recent years. The entity had 1-20 split on the 31st of July 2020. Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. Achieve Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more info on Achieve Life Sciences please contact Richard Stewart at 604 736-3678 or go to https://www.achievelifesciences.com.

Achieve Life Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Achieve Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Achieve Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Achieve Life generated a negative expected return over the last 90 days
Achieve Life has high historical volatility and very poor performance
Achieve Life has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 27.03 M. Net Loss for the year was (31.88 M) with profit before overhead, payroll, taxes, and interest of 5.06 M.
Achieve Life Sciences currently holds about 29.38 M in cash with (29.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03.
Latest headline from www.valuethemarkets.com: Life Sciences Why Investing in Biopharma Could Boost Your Portfolio - Value the Markets

Achieve Life Sciences Upcoming and Recent Events

Earnings reports are used by Achieve Life to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Achieve Life previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report10th of March 2022
Next Financial Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End10th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Achieve Life SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Achieve Life prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Achieve Life investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Achieve Life Sciences specific information freely available to individual and institutional investors to make a timely investment decision.
11th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
1st of June 2022
Submission of Matters to a Vote of Security Holders
View
12th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
27th of April 2022
Financial Statements and Exhibits. Other Events. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Entry into a Material Definitive Agreement
View
14th of March 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
10th of March 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
14th of February 2022
Unclassified Corporate Event
View
29th of December 2021
Unclassified Corporate Event
View

Achieve Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 32.63 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Achieve Life's market, we take the total number of its shares issued and multiply it by Achieve Life's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (48.88) % which means that it has lost $48.88 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (118.04) %, meaning that it created substantial loss on money invested by shareholders. Achieve Life management efficiency ratios could be used to measure how well achieve life sciences manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 29th of September, Achieve Life shows the mean deviation of 2.34, and Risk Adjusted Performance of (0.20). Achieve Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for Achieve Life Sciences, which can be compared to its rivals. Please confirm Achieve Life Sciences variance, as well as the relationship between the value at risk and skewness to decide if Achieve Life Sciences is priced correctly, providing market reflects its regular price of 3.64 per share. Given that Achieve Life has jensen alpha of (0.60), we suggest you to validate Achieve Life Sciences's prevailing market performance to make sure the company can sustain itself at a future point.

Achieve Life Sciences Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Achieve Life Sciences price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.
.

Achieve Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Achieve Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Achieve Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Achieve Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Svb Financial Group over three weeks ago via Macroaxis 
Acquisition or disposition of Achieve Life securities by Svb Financial Group
Svb Financial Group over a month ago via Macroaxis 
Acquisition or disposition of Achieve Life securities by Svb Financial Group
Svb Financial Group over two months ago via Macroaxis 
Acquisition or disposition of Achieve Life securities by Svb Financial Group
Svb Financial Group over three months ago via Macroaxis 
Acquisition or disposition of Achieve Life securities by Svb Financial Group
Martell Bridget A over three months ago via Macroaxis 
Acquisition by Martell Bridget A of 4400 shares of Achieve Life subject to Rule 16b-3
Svb Financial Group over three months ago via Macroaxis 
Acquisition or disposition of Achieve Life securities by Svb Financial Group
Wan Jerry over three months ago via Macroaxis 
Exercise or conversion by Wan Jerry of 1250 shares of Achieve Life subject to Rule 16b-3
Svb Financial Group over three months ago via Macroaxis 
Acquisition or disposition of Achieve Life securities by Svb Financial Group
Himes Vaughn B over six months ago via Macroaxis 
Acquisition by Himes Vaughn B of 6600 shares of Achieve Life subject to Rule 16b-3
Svb Financial Group over six months ago via Macroaxis 
Acquisition or disposition of Achieve Life securities by Svb Financial Group
Anthony Clarke over six months ago via Macroaxis 
Acquisition by Anthony Clarke of 7500 shares of Achieve Life subject to Rule 16b-3
Wan Jerry over six months ago via Macroaxis 
Acquisition by Wan Jerry of 11250 shares of Achieve Life subject to Rule 16b-3

Achieve Life Technical and Predictive Indicators

Achieve Life Forecast Models

Achieve Life time-series forecasting models is one of many Achieve Life's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Achieve Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Achieve Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Achieve Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Achieve shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Achieve Life. By using and applying Achieve Stock analysis, traders can create a robust methodology for identifying Achieve entry and exit points for their positions.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. Achieve Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Current Achieve Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Achieve analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Achieve analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
33.5Strong Buy6Odds
Achieve Life Sciences current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Achieve analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Achieve stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Achieve Life Sciences, talking to its executives and customers, or listening to Achieve conference calls.
Achieve Analyst Advice Details

Achieve Stock Analysis Indicators

Achieve Life Sciences stock analysis indicators help investors evaluate how Achieve Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Achieve Life shares will generate the highest return on investment. By understating and applying Achieve Life stock analysis, traders can identify Achieve Life position entry and exit signals to maximize returns.
Quick Ratio5.54
Fifty Two Week Low3.3700
Shares Short Prior Month307.77k
Average Daily Volume Last 10 Day27.74k
Average Daily Volume In Three Month42.63k
Shares Percent Shares Out3.40%
Short Percent Of Float3.41%
Forward Price Earnings-1.04
Float Shares8.23M
Fifty Two Week High9.5400
Enterprise Value To Ebitda-0.75
Fifty Day Average4.8136
Two Hundred Day Average6.4661
Please continue to Trending Equities. Note that the Achieve Life Sciences information on this page should be used as a complementary analysis to other Achieve Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Achieve Stock analysis

When running Achieve Life Sciences price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Is Achieve Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achieve Life. If investors know Achieve will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achieve Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Achieve Life Sciences is measured differently than its book value, which is the value of Achieve that is recorded on the company's balance sheet. Investors also form their own opinion of Achieve Life's value that differs from its market value or its book value, called intrinsic value, which is Achieve Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achieve Life's market value can be influenced by many factors that don't directly affect Achieve Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achieve Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Achieve Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achieve Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.